NextPlat Corp. (NASDAQ:NXPL – Get Free Report) saw a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 158,290 shares, a drop of 15.2% from the January 29th total of 186,708 shares. Approximately 1.1% of the shares of the company are sold short. Based on an average daily trading volume, of 57,922 shares, the days-to-cover ratio is presently 2.7 days. Based on an average daily trading volume, of 57,922 shares, the days-to-cover ratio is presently 2.7 days. Approximately 1.1% of the shares of the company are sold short.
NextPlat Stock Performance
NASDAQ:NXPL traded down $0.01 during mid-day trading on Wednesday, reaching $0.49. 190,776 shares of the company’s stock were exchanged, compared to its average volume of 688,545. NextPlat has a one year low of $0.43 and a one year high of $1.11. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The business’s fifty day simple moving average is $0.61 and its two-hundred day simple moving average is $0.69. The firm has a market capitalization of $12.80 million, a PE ratio of -1.62 and a beta of 1.26.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.
Institutional Investors Weigh In On NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat as of its most recent filing with the SEC. 1.30% of the stock is owned by institutional investors.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Read More
- Five stocks we like better than NextPlat
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- Your name isn’t on our protected list yet
- 1,500 Banks Just Handed the Fed Your Bank Account
- Elon Musk’s $1 Quadrillion AI IPO
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
